Heart Failure, Congestive Clinical Trial
Official title:
Health Literacy and Self-Management in Heart Failure
Heart failure (HF) affects 5 million people in the United States. Health literacy, which is the ability to read and comprehend important medical information, plays an important role in the health of individuals with HF. This study will evaluate the effectiveness of an educational program developed for various levels of health literacy at improving medical outcomes and quality of life in individuals with HF.
HF is a complicated disease that often requires individuals to carefully monitor their
condition. Individuals with HF must follow strict medication regimens, adhere to diet and
exercise recommendations, and closely monitor symptoms and changes in weight. Individuals
with low health literacy skills may have a harder time comprehending medication dosing
instructions, educational materials, and the overall complexity of managing HF than
individuals with higher health literacy skills. Programs that focus on building self-care
skills have been proven to reduce the rate of hospitalizations among individuals with HF;
only one study, however, has specifically examined the importance of health literacy in the
effectiveness of these programs. Teach to Goal (TTG), a program that focuses on developing
self-care skills while incorporating medical information for various health literacy levels,
may improve medical outcomes in individuals with HF. The purpose of this study is to
evaluate the effectiveness of TTG at improving hospitalization and death rates, quality of
life, and self-care behaviors among individuals with HF.
This 1-year study will enroll individuals with HF. Eligible participants will attend a
baseline study visit and complete survey questionnaires. Participants will then be randomly
assigned to either TTG or a control group. The TTG group will partake in a 30- to 60-minute
educational session, which will focus on improving self-care skills. They will also receive
literacy-sensitive printed materials about monitoring body weight and swelling in the legs,
medication administration, and a sodium reduction and exercise plan. Control group
participants will partake in a shorter educational session and will receive fewer printed
materials. All participants will be provided with a digital scale to self-monitor their
weight at home. The TTG group will receive follow-up phone calls on Days 3, 7, 14, 21, and
28, during which study staff will assess participants' progress and will provide additional
support and training as necessary. Both groups will receive phone calls at Months 1, 6, and
12. During these calls, number of hospitalizations, quality of life, and changes in
self-care behavior and knowledge will be evaluated, but participants will not receive any
additional training.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01357850 -
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
|
Phase 2 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT00383630 -
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
|
Phase 2 | |
Completed |
NCT00531661 -
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
|
N/A | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|
||
Completed |
NCT00241761 -
Epidemiology of Depression and Heart Failure in Aging
|
N/A | |
Completed |
NCT00159614 -
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment
|
Phase 2 | |
Terminated |
NCT00125437 -
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
|
N/A | |
Terminated |
NCT00357591 -
Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation
|
N/A | |
Completed |
NCT00094263 -
Long-Term Predictors of Morbidity in Older Age
|
N/A | |
Completed |
NCT00202579 -
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
|
Phase 2 | |
Completed |
NCT00048425 -
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
|
Phase 3 | |
Completed |
NCT00530426 -
Heart Failure Registry
|
Phase 4 | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Terminated |
NCT00190359 -
Growth Hormone and Heart Failure
|
N/A | |
Completed |
NCT00004562 -
Occluded Artery Trial (OAT)
|
Phase 3 | |
Completed |
NCT00005265 -
Natural History of Coronary Heart Disease
|
N/A | |
Completed |
NCT02772068 -
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
|
Early Phase 1 | |
Completed |
NCT02925546 -
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
|
Phase 1 | |
Completed |
NCT01074307 -
A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
|
Phase 4 |